Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “OBSCHESTVO S OGRANICHENNOI OTVETSTVENNOSTIYU “PHARMENTERPRISES””

19 pharma patents match "OBSCHESTVO S OGRANICHENNOI OTVETSTVENNOSTIYU “PHARMENTERPRISES”" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 19
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 19 pharmaceutical patents matching "OBSCHESTVO S OGRANICHENNOI OTVETSTVENNOSTIYU “PHARMENTERPRISES”" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

19 results for “OBSCHESTVO S OGRANICHENNOI OTVETSTVENNOSTIYU “PHARMENTERPRISES”” · 30,257 patents in full index Clear search

  1. US 10377739

    Glutarimide derivatives, use thereof, pharmaceutical composition based thereon and methods for producing glutarimide derivatives

    OBSCHESTVO S OGRANICHENNOI OTVETSTVENNOSTIYU “PHARMENTERPRISES” · Granted Aug 13, 2019 · Expires Aug 8, 2039

    granted
  2. US 10220029

    Pharmaceutical composition comprising glutarimide derivatives and use thereof in the treatment of eosinophilic diseases

    OBSCHESTVO S OGRANICHENNOI OTVETSTVENNOSTIYU “PHARMENTERPRISES” · Granted Mar 5, 2019 · Expires Feb 28, 2039

    granted
  3. US 10196377

    Glutarimide derivatives, use thereof, pharmaceutical composition based thereon and methods for producing glutarimide derivatives

    OBSCHESTVO S OGRANICHENNOI OTVETSTVENNOSTIYU “PHARMENTERPRISES” · Granted Feb 5, 2019 · Expires Jan 31, 2039

    granted
  4. US 10155746

    Glutarimide derivatives, use thereof, pharmaceutical composition based thereon and methods for producing glutarimide derivatives

    OBSCHESTVO S OGRANICHENNOI OTVETSTVENNOSTIYU “PHARMENTERPRISES” · Granted Dec 18, 2018 · Expires Dec 13, 2038

    granted
  5. US 10155745

    Glutarimide derivatives, use thereof, pharmaceutical composition based thereon and methods for producing glutarimide derivatives

    OBSCHESTVO S OGRANICHENNOI OTVETSTVENNOSTIYU “PHARMENTERPRISES” · Granted Dec 18, 2018 · Expires Dec 13, 2038

    granted
  6. US 10155744

    Glutarimide derivatives, use thereof, pharmaceutical composition based thereon and methods for producing glutarimide derivatives

    OBSCHESTVO S OGRANICHENNOI OTVETSTVENNOSTIYU “PHARMENTERPRISES” · Granted Dec 18, 2018 · Expires Dec 13, 2038

    granted
  7. US 10155743

    Glutarimide derivatives, use thereof, pharmaceutical composition based thereon and methods for producing glutarimide derivatives

    OBSCHESTVO S OGRANICHENNOI OTVETSTVENNOSTIYU “PHARMENTERPRISES” · Granted Dec 18, 2018 · Expires Dec 13, 2038

    granted
  8. US 10155747

    Glutarimide derivatives, use thereof, pharmaceutical composition based thereon and methods for producing glutarimide derivatives

    OBSCHESTVO S OGRANICHENNOI OTVETSTVENNOSTIYU “PHARMENTERPRISES” · Granted Dec 18, 2018 · Expires Dec 13, 2038

    granted
  9. US 9949962

    Pharmaceutical composition comprising glutarimide derivatives and use thereof in the treatment of eosinophilic diseases

    OBSCHESTVO S OGRANICHENNOI OTVETSTVENNOSTIYU “PHARMENTERPRISES” · Granted Apr 24, 2018 · Expires Apr 19, 2038

    granted
  10. US 9820970

    Method and agent for the treatment and prophylaxis of diseases caused by (+)RNA-containing viruses

    OBSCHESTVO S OGRANICHENNOI OTVETSTVENNOSTIYU “PHARMENTERPRISES” · Granted Nov 21, 2017 · Expires Nov 16, 2037

    granted
  11. US 9815814

    Glutarimide derivatives, use thereof, pharmaceutical composition based thereon and methods for producing glutarimide derivatives

    OBSCHESTVO S OGRANICHENNOI OTVETSTVENNOSTIYU “PHARMENTERPRISES” · Granted Nov 14, 2017 · Expires Nov 9, 2037

    granted
  12. US 9730915

    Method for preventing or treating diseases associated with a reduced density of interferon receptors

    OBSCHESTVO S OGRANICHENNOI OTVETSTVENNOSTIYU “PHARMENTERPRISES” · Granted Aug 15, 2017 · Expires Aug 10, 2037

    granted
  13. US 9605013

    Derivatives of hemin with antibacterial and antiviral activity

    OBSCHESTVO S OGRANICHENNOI OTVETSTVENNOSTIYU “PHARMENTERPRISES” · Granted Mar 28, 2017 · Expires Mar 23, 2037

    granted
  14. US 9351960

    Agent for the treatment of viral hepatitis C

    OBSCHESTVO S OGRANICHENNOI OTVETSTVENNOSTIYU “PHARMENTERPRISES” · Granted May 31, 2016 · Expires May 26, 2036

    granted
  15. US 8912185

    Use of glutaric acid derivatives or the pharmaceutically acceptable salts thereof as anti-arrhythmic agents

    OBSCHESTVO S OGRANICHENNOI OTVETSTVENNOSTIYU “PHARMENTERPRISES” · Granted Dec 16, 2014 · Expires Dec 11, 2034

    granted
  16. US 8906897

    Antimicrobial agents based on hemin derivatives

    OBSCHESTVO S OGRANICHENNOI OTVETSTVENNOSTIYU “PHARMENTERPRISES” · Granted Dec 9, 2014 · Expires Dec 4, 2034

    granted
  17. US 8546612

    Phenyl-N-acyl derivatives of amines and amino acids, a process for the preparation thereof, a pharmaceutical composition and use thereof

    OBSCHESTVO S OGRANICHENNOI OTVETSTVENNOSTIYU “PHARMENTERPRISES” · Granted Oct 1, 2013 · Expires Sep 26, 2033

    granted
  18. US 8309766

    Phenyl-containing n-acyl amine and aminoacid derivatives, methods for the production thereof, a pharmaceutical composition and the use thereof

    OBSCHESTVO S OGRANICHENNOI OTVETSTVENNOSTIYU “PHARMENTERPRISES” · Granted Nov 13, 2012 · Expires Nov 8, 2032

    granted
  19. US 7759313

    Induction method for cell differentiation

    OBSCHESTVO S OGRANICHENNOI OTVETSTVENNOSTIYU “PHARMENTERPRISES” · Granted Jul 20, 2010 · Expires Jul 15, 2030

    granted